Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Podocotyle atomon (Trematoda: Digenea) impacts reproductive behaviour, survival and physiology in Gammarus zaddachi (Amphipoda).

Arundell KL, Dubuffet A, Wedell N, Bojko J, Rogers MSJ, Dunn AM.

Dis Aquat Organ. 2019 Oct 2;136(1):51-62. doi: 10.3354/dao03416.

PMID:
31575834
2.

Effectiveness of Police Crisis Intervention Training Programs.

Rogers MS, McNiel DE, Binder RL.

J Am Acad Psychiatry Law. 2019 Dec;47(4):414-421. doi: 10.29158/JAAPL.003863-19. Epub 2019 Sep 24.

PMID:
31551327
3.

A Diet High in Processed Foods, Total Carbohydrates and Added Sugars, and Low in Vegetables and Protein Is Characteristic of Youth with Avoidant/Restrictive Food Intake Disorder.

Harshman SG, Wons O, Rogers MS, Izquierdo AM, Holmes TM, Pulumo RL, Asanza E, Eddy KT, Misra M, Micali N, Lawson EA, Thomas JJ.

Nutrients. 2019 Aug 27;11(9). pii: E2013. doi: 10.3390/nu11092013.

4.

Are 90% of deaths from cancer caused by metastases?

Dillekås H, Rogers MS, Straume O.

Cancer Med. 2019 Sep;8(12):5574-5576. doi: 10.1002/cam4.2474. Epub 2019 Aug 8.

5.

Salicylate 5-Hydroxylase: Intermediates in Aromatic Hydroxylation by a Rieske Monooxygenase.

Rogers MS, Lipscomb JD.

Biochemistry. 2019 May 15. doi: 10.1021/acs.biochem.9b00292. [Epub ahead of print]

PMID:
31066545
6.

Galloyl Carbohydrates with Antiangiogenic Activity Mediated by Capillary Morphogenesis Gene 2 (CMG2) Protein Binding.

G-Doyagüez E, Carrero P, Madrona A, Rodriguez-Salamanca P, Martínez-Gualda B, Camarasa MJ, Jimeno ML, Bennallack PR, Finnell JG, Tsang TM, Christensen KA, San-Félix A, Rogers MS.

J Med Chem. 2019 Apr 25;62(8):3958-3970. doi: 10.1021/acs.jmedchem.8b01988. Epub 2019 Apr 9.

PMID:
30964669
7.

Developing a novel FRET assay, targeting the binding between Antizyme-AZIN.

Ghalali A, Rice JM, Kusztos A, Jernigan FE, Zetter BR, Rogers MS.

Sci Rep. 2019 Mar 15;9(1):4632. doi: 10.1038/s41598-019-40929-4.

8.

A paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor.

Dao DT, Anez-Bustillos L, Jabbouri SS, Pan A, Kishikawa H, Mitchell PD, Fell GL, Baker MA, Watnick RS, Chen H, Rogers MS, Bielenberg DR, Puder M.

PLoS One. 2018 Dec 19;13(12):e0208579. doi: 10.1371/journal.pone.0208579. eCollection 2018.

9.

Nuclear Resonance Vibrational Spectroscopy Definition of O2 Intermediates in an Extradiol Dioxygenase: Correlation to Crystallography and Reactivity.

Sutherlin KD, Wasada-Tsutsui Y, Mbughuni MM, Rogers MS, Park K, Liu LV, Kwak Y, Srnec M, Böttger LH, Frenette M, Yoda Y, Kobayashi Y, Kurokuzu M, Saito M, Seto M, Hu M, Zhao J, Alp EE, Lipscomb JD, Solomon EI.

J Am Chem Soc. 2018 Dec 5;140(48):16495-16513. doi: 10.1021/jacs.8b06517. Epub 2018 Nov 26.

10.

Heparin impairs angiogenic signaling and compensatory lung growth after left pneumonectomy.

Dao DT, Anez-Bustillos L, Ourieff J, Pan A, Mitchell PD, Kishikawa H, Fell GL, Baker MA, Watnick RS, Chen H, Hamilton TE, Rogers MS, Bielenberg DR, Puder M.

Angiogenesis. 2018 Nov;21(4):837-848. doi: 10.1007/s10456-018-9628-3. Epub 2018 Jun 28.

11.

NRVS Studies of the Peroxide Shunt Intermediate in a Rieske Dioxygenase and Its Relation to the Native FeII O2 Reaction.

Sutherlin KD, Rivard BS, Böttger LH, Liu LV, Rogers MS, Srnec M, Park K, Yoda Y, Kitao S, Kobayashi Y, Saito M, Seto M, Hu M, Zhao J, Lipscomb JD, Solomon EI.

J Am Chem Soc. 2018 Apr 25;140(16):5544-5559. doi: 10.1021/jacs.8b01822. Epub 2018 Apr 11.

12.

Identification of Padi2 as a novel angiogenesis-regulating gene by genome association studies in mice.

Khajavi M, Zhou Y, Birsner AE, Bazinet L, Rosa Di Sant A, Schiffer AJ, Rogers MS, Krishnaji ST, Hu B, Nguyen V, Zon L, D'Amato RJ.

PLoS Genet. 2017 Jun 15;13(6):e1006848. doi: 10.1371/journal.pgen.1006848. eCollection 2017 Jun.

13.

Enzyme Substrate Complex of the H200C Variant of Homoprotocatechuate 2,3-Dioxygenase: Mössbauer and Computational Studies.

Meier KK, Rogers MS, Kovaleva EG, Lipscomb JD, Bominaar EL, Münck E.

Inorg Chem. 2016 Jun 20;55(12):5862-70. doi: 10.1021/acs.inorgchem.6b00148. Epub 2016 Jun 8.

14.

Electronic Medical Record Validation: Exploring the Reliability of Intracranial Pressure Data Abstracted From the Electronic Medical Record-Pilot.

Olson DM, Rogers MS, Stutzman SE.

J Nurs Meas. 2015 Dec 1;23(3):532-540. doi: 10.1891/1061-3749.23.3.532.

PMID:
28234194
15.

A Long-Lived Fe(III)-(Hydroperoxo) Intermediate in the Active H200C Variant of Homoprotocatechuate 2,3-Dioxygenase: Characterization by Mössbauer, Electron Paramagnetic Resonance, and Density Functional Theory Methods.

Meier KK, Rogers MS, Kovaleva EG, Mbughuni MM, Bominaar EL, Lipscomb JD, Münck E.

Inorg Chem. 2015 Nov 2;54(21):10269-80. doi: 10.1021/acs.inorgchem.5b01576. Epub 2015 Oct 20.

16.

Structural Basis for Substrate and Oxygen Activation in Homoprotocatechuate 2,3-Dioxygenase: Roles of Conserved Active Site Histidine 200.

Kovaleva EG, Rogers MS, Lipscomb JD.

Biochemistry. 2015 Sep 1;54(34):5329-39. doi: 10.1021/acs.biochem.5b00709. Epub 2015 Aug 19.

17.

Rate-Determining Attack on Substrate Precedes Rieske Cluster Oxidation during Cis-Dihydroxylation by Benzoate Dioxygenase.

Rivard BS, Rogers MS, Marell DJ, Neibergall MB, Chakrabarty S, Cramer CJ, Lipscomb JD.

Biochemistry. 2015 Aug 4;54(30):4652-64. doi: 10.1021/acs.biochem.5b00573. Epub 2015 Jul 21.

18.

Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors.

Rogers MS, Novak K, Zurakowski D, Cryan LM, Blois A, Lifshits E, Bø TH, Oyan AM, Bender ER, Lampa M, Kang SY, Naxerova K, Kalland KH, Straume O, Akslen LA, Watnick RS, Folkman J, Naumov GN.

Mol Cancer Res. 2014 May;12(5):754-64. doi: 10.1158/1541-7786.MCR-13-0532-T. Epub 2014 Feb 26.

19.

Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment.

Adini I, Ghosh K, Adini A, Chi ZL, Yoshimura T, Benny O, Connor KM, Rogers MS, Bazinet L, Birsner AE, Bielenberg DR, D'Amato RJ.

J Clin Invest. 2014 Jan;124(1):425-36. doi: 10.1172/JCI69404. Epub 2013 Dec 20.

20.

Pomalidomide is strongly antiangiogenic and teratogenic in relevant animal models.

D'Amato RJ, Lentzsch S, Rogers MS.

Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):E4818. doi: 10.1073/pnas.1315875110. Epub 2013 Dec 3. No abstract available.

21.

Nanomedicine for prion disease treatment: new insights into the role of dendrimers.

McCarthy JM, Appelhans D, Tatzelt J, Rogers MS.

Prion. 2013 May-Jun;7(3):198-202. doi: 10.4161/pri.24431.

22.

Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay.

Cryan LM, Habeshian KA, Caldwell TP, Morris MT, Ackroyd PC, Christensen KA, Rogers MS.

J Biomol Screen. 2013 Jul;18(6):714-25. doi: 10.1177/1087057113478655. Epub 2013 Mar 11.

23.

The albino mutation of tyrosinase alters ocular angiogenic responsiveness.

Rogers MS, Adini I, McBride AF, Birsner AE, D'Amato RJ.

Angiogenesis. 2013 Jul;16(3):639-46. doi: 10.1007/s10456-013-9342-0. Epub 2013 Feb 20.

24.

1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2.

Cryan LM, Bazinet L, Habeshian KA, Cao S, Clardy J, Christensen KA, Rogers MS.

J Med Chem. 2013 Mar 14;56(5):1940-5. doi: 10.1021/jm301558t. Epub 2013 Feb 22.

25.

Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc).

McCarthy JM, Franke M, Resenberger UK, Waldron S, Simpson JC, Tatzelt J, Appelhans D, Rogers MS.

PLoS One. 2013;8(1):e55282. doi: 10.1371/journal.pone.0055282. Epub 2013 Jan 28.

26.

Influence of surface groups on poly(propylene imine) dendrimers antiprion activity.

McCarthy JM, Rasines Moreno B, Filippini D, Komber H, Maly M, Cernescu M, Brutschy B, Appelhans D, Rogers MS.

Biomacromolecules. 2013 Jan 14;14(1):27-37. doi: 10.1021/bm301165u. Epub 2012 Dec 26.

PMID:
23234313
27.

Common polymorphisms in angiogenesis.

Rogers MS, D'Amato RJ.

Cold Spring Harb Perspect Med. 2012 Nov 1;2(11). pii: a006510. doi: 10.1101/cshperspect.a006510. Review.

28.

Quantification and structure elucidation of in vivo bevacizumab modification in rabbit vitreous humor after intravitreal injection.

Chu KO, Liu DT, Chan KP, Yang YP, Yam GH, Rogers MS, Pang CP.

Mol Pharm. 2012 Dec 3;9(12):3422-33. doi: 10.1021/mp3005403. Epub 2012 Nov 6.

PMID:
23094698
29.

Phenolic compounds as antiangiogenic CMG2 inhibitors from Costa Rican endophytic fungi.

Cao S, Cryan L, Habeshian KA, Murillo C, Tamayo-Castillo G, Rogers MS, Clardy J.

Bioorg Med Chem Lett. 2012 Sep 15;22(18):5885-8. doi: 10.1016/j.bmcl.2012.07.075. Epub 2012 Aug 3.

30.

A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.

Rogers MS, Cryan LM, Habeshian KA, Bazinet L, Caldwell TP, Ackroyd PC, Christensen KA.

PLoS One. 2012;7(6):e39911. doi: 10.1371/journal.pone.0039911. Epub 2012 Jun 29.

31.

The classical pink-eyed dilution mutation affects angiogenic responsiveness.

Rogers MS, Boyartchuk V, Rohan RM, Birsner AE, Dietrich WF, D'Amato RJ.

PLoS One. 2012;7(5):e35237. doi: 10.1371/journal.pone.0035237. Epub 2012 May 15.

32.

Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy.

Cryan LM, Rogers MS.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1574-88. Review.

33.

Effects of different inspired oxygen fractions on lipid peroxidation during general anaesthesia for elective Caesarean section.

Khaw KS, Ngan Kee WD, Chu CY, Ng FF, Tam WH, Critchley LA, Rogers MS, Wang CC.

Br J Anaesth. 2010 Sep;105(3):355-60. doi: 10.1093/bja/aeq154. Epub 2010 Jun 24.

34.

Urgent cesarean delivery for fetal bradycardia.

Leung TY, Chung PW, Rogers MS, Sahota DS, Lao TT, Hung Chung TK.

Obstet Gynecol. 2009 Nov;114(5):1023-8. doi: 10.1097/AOG.0b013e3181bc6e15.

PMID:
20168102
35.

Green tea catechins and their oxidative protection in the rat eye.

Chu KO, Chan KP, Wang CC, Chu CY, Li WY, Choy KW, Rogers MS, Pang CP.

J Agric Food Chem. 2010 Feb 10;58(3):1523-34. doi: 10.1021/jf9032602.

PMID:
20085274
36.

Can cancer patients influence the pain agenda in oncology outpatient consultations?

Rogers MS, Todd C.

J Pain Symptom Manage. 2010 Feb;39(2):268-82. doi: 10.1016/j.jpainsymman.2009.05.024. Epub 2009 Dec 5.

PMID:
19963336
37.

Genetic loci that control the size of laser-induced choroidal neovascularization.

Nakai K, Rogers MS, Baba T, Funakoshi T, Birsner AE, Luyindula DS, D'Amato RJ.

FASEB J. 2009 Jul;23(7):2235-43. doi: 10.1096/fj.08-124321. Epub 2009 Feb 23.

38.

Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.

Xu H, Lui WT, Chu CY, Ng PS, Wang CC, Rogers MS.

Hum Reprod. 2009 Mar;24(3):608-18. doi: 10.1093/humrep/den417. Epub 2008 Dec 16.

PMID:
19088106
39.

Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero.

Tam WH, Ma RC, Yang X, Ko GT, Tong PC, Cockram CS, Sahota DS, Rogers MS, Chan JC.

Pediatrics. 2008 Dec;122(6):1229-34. doi: 10.1542/peds.2008-0158.

PMID:
19047239
40.

Supplementary oxygen for emergency Caesarean section under regional anaesthesia.

Khaw KS, Wang CC, Ngan Kee WD, Tam WH, Ng FF, Critchley LA, Rogers MS.

Br J Anaesth. 2009 Jan;102(1):90-6. doi: 10.1093/bja/aen321. Epub 2008 Nov 16.

41.

Cross-link formation of the cysteine 228-tyrosine 272 catalytic cofactor of galactose oxidase does not require dioxygen.

Rogers MS, Hurtado-Guerrero R, Firbank SJ, Halcrow MA, Dooley DM, Phillips SE, Knowles PF, McPherson MJ.

Biochemistry. 2008 Sep 30;47(39):10428-39. doi: 10.1021/bi8010835. Epub 2008 Sep 5.

42.

High isoprostane level in cardinal ligament-derived fibroblasts and urine sample of women with uterine prolapse.

Choy KW, Liu YM, Chu CY, Wang CC, Lui WT, Lee LL, Pang MW, Rogers MS, Yip SK.

BJOG. 2008 Aug;115(9):1179-83. doi: 10.1111/j.1471-0528.2008.01806.x.

43.

Hyperglycemia and adverse pregnancy outcomes.

HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA.

N Engl J Med. 2008 May 8;358(19):1991-2002. doi: 10.1056/NEJMoa0707943.

44.

Sonographic examination of uteroplacental separation during the third stage of labor.

Mo A, Rogers MS.

Ultrasound Obstet Gynecol. 2008 Apr;31(4):427-31. doi: 10.1002/uog.5293.

45.

A three-dimensional anthropometric solid model of the hand based on landmark measurements.

Rogers MS, Barr AB, Kasemsontitum B, Rempel DM.

Ergonomics. 2008 Apr;51(4):511-26. doi: 10.1080/00140130701710994.

PMID:
18357538
46.

The mouse cornea micropocket angiogenesis assay.

Rogers MS, Birsner AE, D'Amato RJ.

Nat Protoc. 2007;2(10):2545-50.

PMID:
17947997
47.

Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.

Rogers MS, Christensen KA, Birsner AE, Short SM, Wigelsworth DJ, Collier RJ, D'Amato RJ.

Cancer Res. 2007 Oct 15;67(20):9980-5.

48.

Prediction of pre-eclampsia in early pregnancy.

Rogers MS.

Womens Health (Lond). 2007 Sep;3(5):571-82. doi: 10.2217/17455057.3.5.571.

PMID:
19804034
49.

Method to determine stability and recovery of carboprost and misoprostol in infusion preparations.

Chu KO, Wang CC, Pang CP, Rogers MS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 15;857(1):83-91. Epub 2007 Jul 13.

PMID:
17692579
50.

Tea epigallocatechin-3-gallate increases 8-isoprostane level and induces caudal regression in developing rat embryos.

Wang CC, Chu KO, Chong WS, Li WY, Pang CP, Shum AS, Lau TK, Rogers MS.

Free Radic Biol Med. 2007 Aug 15;43(4):519-27. Epub 2007 May 31.

PMID:
17640562

Supplemental Content

Loading ...
Support Center